Related Experiment Video
Updated: Mar 23, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies
Riccardo Pofi, Francesca Di Mario, Antonietta Gigante
1Department of Clinical Medicine, Sapienza University of Rome,Viale del Policlinico 15500161 - Rome - Italy. biagionet@hotmail.com.
Background:
Diabetic nephropathy (DN) is currently the most common cause of end-stage renal disease (ESRD). Although nowadays much is known about its classification, pathogenesis, clinical manifestations and evolution, to date we are not yet able to stop the natural progression of nephropathy in diabetic patients.
Methods:
Treatment options are: lifestyle change with close blood pressure monitoring and tight glycemic control. The most common therapies adopted for this condition are Angiotensing Converting Enzyme-inhibitors (ACEi). However these drugs are able to block the progression of renal damage only in a small proportion of patients. In the remaining, DN progresses and may evolve into ESRD.
Conclusion:
The purpose of this review is to summarize the "state of art" of current novel therapeutic strategies to stem this debilitating kidney disease.
More Related Videos
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care

